Solazyme Reports Second Quarter 2015 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall St indexes fall to two-week lows as rising bond yields, disappointing Walmart results drag
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
Cowen Cuts Price Target on Solazyme (SZYM) Following Earnings Results
July 31, 2015 7:56 AM EDTCowen maintained a Market Perform rating on Solazyme (NASDAQ: SZYM), and cut the price target to $3.25 (from $4.00), following its earnings results. Solazyme reported $11.7mn in revenue for the quarter, missing consensus estimates of and $14.3mn. Adjusted EPS was ($0.40) versus consensus estimate of ($0.37).
Analyst... More
Solazyme (SZYM) Misses Q2 EPS by 4c
July 30, 2015 4:22 PM EDTSolazyme (NASDAQ: SZYM) reported Q2 EPS of ($0.40), $0.04 worse than the analyst estimate of ($0.36). Revenue for the quarter came in at $11.7 million versus the consensus estimate of $14.34 million.
We are making good progress against our core deliverables, the commercialization of high value products across... More
